MIDAS VERDICT:

Treatt shareholders who bought in 2014 are still in the money but they have received quite a bruising this year and deserve to feel aggrieved. Nonetheless, now is not the time to sell. Treatt is expected to find its feet again next year and valuable lessons have been learned from the recent maelstrom. Brave investors may even want to follow the directors’ lead and dip a toe in the Treatt waters at £5.69.